FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4254143467> ?p ?o ?g. }

• W4254143467 endingPage "3044" @default.
• W4254143467 startingPage "3036" @default.
• W4254143467 abstract "High-dose therapy with autologous marrow support results in durable complete remissions in selected patients with relapsed lymphoma and leukemia who cannot be cured with conventional dose therapy. However, substantial morbidity and mortality result from the 3- to 6-week period of marrow aplasia until the reinfused marrow recovers adequate hematopoietic function. Hematopoietic growth factors, particularly used after chemotherapy, can increase the number of peripheral blood progenitor cells (PBPCs) present in systemic circulation. The reinfusion of PBPCs with marrow has recently been reported to reduce the time to recovery of adequate marrow function. This study was designed to determine whether granulocyte-macrophage colony-stimulating factor (GM-CSF)-mobilized PBPCs alone (without marrow) would result in rapid and reliable hematopoietic reconstitution. Sixteen patients with metastatic breast cancer were treated with four cycles of doxorubicin, 5-fluorouracil, and methotrexate (AFM induction). Patients responding after the first two cycles were administered GM-CSF after the third and fourth cycles to recruit PBPCs for collection by two leukapheresis per cycle. These PBPCs were reinfused as the sole source of hematopoietic support after high doses of cyclophosphamide, thiotepa, and carboplatin. No marrow or hematopoietic cytokines were used after progenitor cell reinfusion. Granulocytes greater than or equal to 500/microL was observed on a median of day 14 (range, 8 to 57). Transfusion independence of platelets greater than or equal to 20,000/microL occurred on a median day of 12 (range, 8 to 134). However, three patients required the use of a reserve marrow for slow platelet engraftment. In retrospect, these patients were characterized by poor baseline bone marrow cellularity and poor platelet recovery after AFM induction therapy. When compared with 29 historical control patients who had received the same high-dose intensification chemotherapy using autologous marrow support, time to engraftment, antibiotic days, transfusion requirements, and lengths of hospital stay were all significantly improved for the patients receiving PBPCs. Thus, autologous PBPCs can be efficiently collected during mobilization by chemotherapy and GM-CSF and are an attractive alternative to marrow for hematopoietic support after high-dose therapy. The enhanced speed of recovery may reduce the morbidity, mortality, and cost of high-dose treatment. Furthermore, PBPC support may enhance the effectiveness of high-dose therapy by facilitating multiple courses of therapy." @default.
• W4254143467 created "2022-05-12" @default.
• W4254143467 creator A5000104295 @default.
• W4254143467 creator A5014276455 @default.
• W4254143467 creator A5031965363 @default.
• W4254143467 creator A5032226688 @default.
• W4254143467 creator A5047995423 @default.
• W4254143467 creator A5067304055 @default.
• W4254143467 creator A5072148862 @default.
• W4254143467 creator A5078356097 @default.
• W4254143467 creator A5091089490 @default.
• W4254143467 creator A5091892801 @default.
• W4254143467 date "1992-06-01" @default.
• W4254143467 modified "2023-10-15" @default.
• W4254143467 title "Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer" @default.
• W4254143467 doi "https://doi.org/10.1182/blood.v79.11.3036.bloodjournal79113036" @default.
• W4254143467 hasPublicationYear "1992" @default.
• W4254143467 type Work @default.
• W4254143467 citedByCount "1" @default.
• W4254143467 crossrefType "journal-article" @default.
• W4254143467 hasAuthorship W4254143467A5000104295 @default.
• W4254143467 hasAuthorship W4254143467A5014276455 @default.
• W4254143467 hasAuthorship W4254143467A5031965363 @default.
• W4254143467 hasAuthorship W4254143467A5032226688 @default.
• W4254143467 hasAuthorship W4254143467A5047995423 @default.
• W4254143467 hasAuthorship W4254143467A5067304055 @default.
• W4254143467 hasAuthorship W4254143467A5072148862 @default.
• W4254143467 hasAuthorship W4254143467A5078356097 @default.
• W4254143467 hasAuthorship W4254143467A5091089490 @default.
• W4254143467 hasAuthorship W4254143467A5091892801 @default.
• W4254143467 hasBestOaLocation W42541434671 @default.
• W4254143467 hasConcept C10205521 @default.
• W4254143467 hasConcept C109159458 @default.
• W4254143467 hasConcept C126322002 @default.
• W4254143467 hasConcept C201750760 @default.
• W4254143467 hasConcept C203014093 @default.
• W4254143467 hasConcept C2776689292 @default.
• W4254143467 hasConcept C2776694085 @default.
• W4254143467 hasConcept C2776755627 @default.
• W4254143467 hasConcept C2777371436 @default.
• W4254143467 hasConcept C2777767877 @default.
• W4254143467 hasConcept C2779958370 @default.
• W4254143467 hasConcept C2779968505 @default.
• W4254143467 hasConcept C2780007613 @default.
• W4254143467 hasConcept C28328180 @default.
• W4254143467 hasConcept C54355233 @default.
• W4254143467 hasConcept C71924100 @default.
• W4254143467 hasConcept C86803240 @default.
• W4254143467 hasConcept C89560881 @default.
• W4254143467 hasConceptScore W4254143467C10205521 @default.
• W4254143467 hasConceptScore W4254143467C109159458 @default.
• W4254143467 hasConceptScore W4254143467C126322002 @default.
• W4254143467 hasConceptScore W4254143467C201750760 @default.
• W4254143467 hasConceptScore W4254143467C203014093 @default.
• W4254143467 hasConceptScore W4254143467C2776689292 @default.
• W4254143467 hasConceptScore W4254143467C2776694085 @default.
• W4254143467 hasConceptScore W4254143467C2776755627 @default.
• W4254143467 hasConceptScore W4254143467C2777371436 @default.
• W4254143467 hasConceptScore W4254143467C2777767877 @default.
• W4254143467 hasConceptScore W4254143467C2779958370 @default.
• W4254143467 hasConceptScore W4254143467C2779968505 @default.
• W4254143467 hasConceptScore W4254143467C2780007613 @default.
• W4254143467 hasConceptScore W4254143467C28328180 @default.
• W4254143467 hasConceptScore W4254143467C54355233 @default.
• W4254143467 hasConceptScore W4254143467C71924100 @default.
• W4254143467 hasConceptScore W4254143467C86803240 @default.
• W4254143467 hasConceptScore W4254143467C89560881 @default.
• W4254143467 hasIssue "11" @default.
• W4254143467 hasLocation W42541434671 @default.
• W4254143467 hasOpenAccess W4254143467 @default.
• W4254143467 hasPrimaryLocation W42541434671 @default.
• W4254143467 hasRelatedWork W1567835511 @default.
• W4254143467 hasRelatedWork W1858144598 @default.
• W4254143467 hasRelatedWork W1962943827 @default.
• W4254143467 hasRelatedWork W2008675714 @default.
• W4254143467 hasRelatedWork W2011495040 @default.
• W4254143467 hasRelatedWork W2017352244 @default.
• W4254143467 hasRelatedWork W2054997369 @default.
• W4254143467 hasRelatedWork W2097466377 @default.
• W4254143467 hasRelatedWork W2584002308 @default.
• W4254143467 hasRelatedWork W90612167 @default.
• W4254143467 hasVolume "79" @default.
• W4254143467 isParatext "false" @default.
• W4254143467 isRetracted "false" @default.
• W4254143467 workType "article" @default.